Differential effects of peroxisome proliferator activated receptor-γ (PPARγ) ligands in proximal tubular cells:: Thiazolidinediones are partial PPARγ agonists

被引:44
作者
Chana, RS
Lewington, AJ
Brunskill, NJ
机构
[1] Univ Leicester, Dept Cell Physiol & Pharmacol, Fac Med & Biol Sci, Leicester LE1 9HN, Leics, England
[2] Univ Leicester, Dept Nephrol, Fac Med & Biol Sci, Leicester LE1 9HN, Leics, England
关键词
proximal tubule; PPAR; thiazolidinedione; ciglitazone; troglitazone prostaglandin; partial agonist; MAP kinase; phosphorylation;
D O I
10.1111/j.1523-1755.2004.00624.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Peroxisome proliferator activated receptors (PPARs) are ligand-activated transcription factors with multiple effects on target cell function. PPARgamma activity is regulated by extracellular signal-regulated protein kinase (ERK), mitogen-activated protein (MAP) kinase, and PPARgamma ligands have varying effects on activity of ERK. Different PPARgamma ligands have been shown to have both protective and detrimental effects in the kidney. Since transcriptional activation by different PPAR agonists is ligand- and depot-specific PPARgamma, we have examined the effects of different agonists on PPAR activity in the proximal tubule. Methods. Opossum kidney cells were used in all experiments, transiently transfected with a PPAR response element luciferase reporter and subject to stimulation with various PPAR ligands. The role of ERK and phosphorylation in PPARgamma activation were studied, as were the effects of PPAR agonists on ERK activation and cell proliferation. Results. Transcriptional activity of PPAR was not stimulated by PPARalpha agonists, and only very modestly stimulated by a PPARbeta agonist. The PPARgamma agonists 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)), ciglitazone, and troglitazone stimulated significant transcriptional activation and phosphorylation of PPARgamma. These effects were more marked with 15d-PGJ(2). Thiazolidinediones attenuated 15d-PGJ(2) evoked PPARgamma activation and phosphorylation. ERK activity positively regulated PPAR activation. Only 15d-PGJ(2) stimulated ERK activity and cell proliferation, and these effects were also inhibited by thiazolidinediones. Conclusion. PPARgamma agonists exert differential effects in proximal tubule cells with thiazolidinediones behaving as partial agonists.
引用
收藏
页码:2081 / 2090
页数:10
相关论文
共 47 条
  • [1] Activators of peroxisome proliferator-activated receptor γ have depot-specific effects on human preadipocyte differentiation
    Adams, M
    Montague, CT
    Prins, JB
    Holder, JC
    Smith, SA
    Sanders, L
    Digby, JE
    Sewter, CP
    Lazar, MA
    Chatterjee, VKK
    O'Rahilly, S
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (12) : 3149 - 3153
  • [2] Stimulation of proximal tubular cell apoptosis by albumin-bound fatty acids mediated by peroxisome proliferator activated receptor-γ
    Arici, M
    Chana, R
    Lewington, A
    Brown, J
    Brunskill, NJ
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (01): : 17 - 27
  • [3] Troglitazone, a peroxisome proliferator-activated receptor γ (PPARγ) ligand, selectively induces the early growth response-1 gene independently of PPARγ -: A novel mechanism for its anti-tumorigenic activity
    Baek, SJ
    Wilson, LC
    Hsi, LC
    Eling, TE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (08) : 5845 - 5853
  • [4] In vivo identification of the mitogen-activated protein kinase cascade as a central pathogenic pathway in experimental mesangioproliferative glomerulonephritis
    Bokemeyer, D
    Panek, D
    Kramer, HJ
    Lindemann, M
    Kitahara, M
    Boor, P
    Kerjaschki, D
    Trzaskos, JM
    Floege, J
    Ostendorf, T
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (06): : 1473 - 1480
  • [5] Multiple intracellular MAP kinase signaling cascades
    Bokemeyer, D
    Sorokin, A
    Dunn, MJ
    [J]. KIDNEY INTERNATIONAL, 1996, 49 (05) : 1187 - 1198
  • [6] A non-thiazolidinedione partial peroxisome proliferator-activated receptor γ ligand inhibits vascular smooth muscle cell growth
    Bruemmer, D
    Berger, JP
    Liu, J
    Kintscher, U
    Wakino, S
    Fleck, E
    Moller, DE
    Law, RE
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 466 (03) : 225 - 234
  • [7] c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-γ1 and negatively regulates its transcriptional activity
    Camp, HS
    Tafuri, SR
    Leff, T
    [J]. ENDOCRINOLOGY, 1999, 140 (01) : 392 - 397
  • [8] Differential activation of peroxisome proliferator-activated receptor-γ by troglitazone and rosiglitazone
    Camp, HS
    Li, O
    Wise, SC
    Hong, YH
    Frankowski, CL
    Shen, XQ
    Vanbogelen, R
    Leff, T
    [J]. DIABETES, 2000, 49 (04) : 539 - 547
  • [9] Camp HS, 1997, J BIOL CHEM, V272, P10811
  • [10] PTHrP inhibits adipocyte differentiation by down-regulating PPARγ activity via a MAPK-dependent pathway
    Chan, GK
    Deckelbaum, RA
    Bolivar, I
    Goltzman, D
    Karaplis, AC
    [J]. ENDOCRINOLOGY, 2001, 142 (11) : 4900 - 4909